期刊文献+

原发性骨髓纤维化转急性髓系白血病M6一例并文献复习 被引量:1

原文传递
导出
摘要 目的 探讨罕见的原发性骨髓纤维化(PMF)转化为急性髓系白血病(AML)M6的疾病进展过程,对其机制及目前的临床治疗进行探讨并复习文献。方法 回顾性分析1例PMF转AML-M6患者转化前后的临床资料。结果 患者转白血病前后JAK2 V617F基因突变均为阴性,转化后新出现了+8和del(X)(q22)染色体异常。患者从诊断为PMF到转化为白血病的时间为16个月。结论 PMF转化为AML-M6罕见,患者临床预后差,生存期短。
出处 《白血病.淋巴瘤》 CAS 2013年第3期176-178,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献12

  • 1Mesa RA, Li CY, Ketterling RP, et al. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood, 2005, 105: 973-977.
  • 2Garcia S, Miguel A, Miguel A, et al. Idiopathic myelofibrosis terminating in erythroleukemia. Am J Hematol, 1989, 32: 70-71.
  • 3Kundranda MN, Tibes R, Mesa RA. Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work. Curt Hematol Malig Rep, 2012, 7: 78-86.
  • 4Tiedt R, Hao-shen H, Sobas MA, et al. Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Blood, 2008, 111: 3931-3940.
  • 5Theocharides A, Boissinot M, Girodon F, et al. Leukemic blasts intransformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutalion. Blood, 2007, 110: 375-379.
  • 6Panlssan K, Fioretos T, Strombeck B, et al. Trisomy 8 as the sole chromosomal aberration in myelocytie malignancies, a multicolor and locus-specific fluoreseence in situ hybridization study. Cancer Genet Cytogenet, 2003, 140: 66-69.
  • 7Petti MC, Latagliata R, Spadea T, et al. Melphalan treatment in patients with myelofibrosis with myeloid metaplasia. Br J Hematol, 2002, 116: 576-581.
  • 8Finazzi G, Caruso V, Marchioli R, et al. Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood, 2005, 105: 2664-2670.
  • 9Barosi G, Ambrosetti A, Centra A, et al. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Blood, 1998, 91: 3630-3636.
  • 10Huang J, Li CY, Mesa RA, et al. Risk factors for leukemic transformation in patients with primary myelofibrosis. Cancer, 2008, 112: 2726-2732.

同被引文献22

  • 1聂波,杨绵本,魏彩霞,李维佳,石琳熙.WT1基因在白血病患者中的表达及临床意义[J].白血病.淋巴瘤,2006,15(1):24-26. 被引量:8
  • 2张之南,沈悌.血液病诊断及疗效标准.3版.北京:科学出版社,2008:220-227.
  • 3Brito-Babopulle F, Catovsky D, Galton DA, et al. Clinical and laboralory features of de novo acute myeloid leukemia with trilineage myelodysplasia. Br J Haemalol, 1987, 66: 445-450.
  • 4Goasguen JE, Matsuo T, Cox C, et al. Evaluation o f the dysmyelopiesis in 336 patients with de novo acute myeloid leukemia, major importance of dysgTanulopoiesis for remisson and survival. Leukemia, 1992, 6: 520-525.
  • 5Arber DA, Bnning RD, Orazi A, et al. Acute myeloid leukemia, not otherwise specified//Swerdlow S, Campo E, Harris N, Jaffe E, et al. WHO classification of turnouts of haematopoietic and lymphoid tissue, 4th ed. Lyon: IARC Press. 2008.
  • 6Domingo-Claros A, Larriba I,Rozman M, et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematoloica, 2002, 87: 148-153.
  • 7Bene MC, Castoldi G, Knapp W, et al. Propasals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 1995, 9: 1783-1786.
  • 8Kasyan A, Medeiros LJ, Zuo Z, et al. Acute erythroid leukemia as defined in the World Health Organization classificalion is a rare and pathogenetically heterogeneous disease. Mod Pathol, 2010, 23:1113- 1126.
  • 9Kuchenbauer F, Kern W, Schoch C, et al. Detailed analysis of FLT3 expression levels in acute myeloid leukemia. Haematologica, 2005, 90: 1617-1625.
  • 10Hasserjian lip, Zuo Z, Garcia C, et al. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO Classification. Blood, 2010, 115: 1985-1992.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部